Positron Emission Tomography (PET) Systems - Medical Devices Pipeline Assessment, 2017

Published : Jun-2017

No. of Pages : 79

order by fax Inquire before Buying request discount

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Positron Emission Tomography (PET) Systems Overview 7
3 Products under Development 8
3.1 Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development 8
3.2 Positron Emission Tomography (PET) Systems - Pipeline Products by Territory 9
3.3 Positron Emission Tomography (PET) Systems - Pipeline Products by Regulatory Path 10
3.4 Positron Emission Tomography (PET) Systems - Pipeline Products by Estimated Approval Date 11
4 Positron Emission Tomography (PET) Systems - Pipeline Products under Development by Companies 12
4.1 Positron Emission Tomography (PET) Systems Companies - Pipeline Products by Stage of Development 12
4.2 Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development 13
5 Positron Emission Tomography (PET) Systems Companies and Product Overview 14
5.1 Brain Biosciences Inc Company Overview 14
5.1.1 Brain Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 14
5.2 GE Healthcare LLC Company Overview 15
5.2.1 GE Healthcare LLC Pipeline Products & Ongoing Clinical Trials Overview 15
5.3 General De Equipment for Medical Imaging SA Company Overview 16
5.3.1 General De Equipment for Medical Imaging SA Pipeline Products & Ongoing Clinical Trials Overview 16
5.4 Jagiellonian University Company Overview 17
5.4.1 Jagiellonian University Pipeline Products & Ongoing Clinical Trials Overview 17
5.5 Philips Healthcare Company Overview 18
5.5.1 Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview 18
5.6 Ray Vision Intl Corp. Company Overview 19
5.6.1 Ray Vision Intl Corp. Pipeline Products & Ongoing Clinical Trials Overview 19
5.7 Stanford University Company Overview 20
5.7.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 20
5.8 SynchroPET Company Overview 25
5.8.1 SynchroPET Pipeline Products & Ongoing Clinical Trials Overview 25
5.9 University of British Columbia Company Overview 27
5.9.1 University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview 27
5.10 University of Washington Company Overview 28
5.10.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview 28
5.11 West Virginia University Company Overview 31
5.11.1 West Virginia University Pipeline Products & Ongoing Clinical Trials Overview 31
5.12 Zecotek Photonics Inc Company Overview 32
5.12.1 Zecotek Photonics Inc Pipeline Products & Ongoing Clinical Trials Overview 32
6 Positron Emission Tomography (PET) Systems- Recent Developments 33
6.1 Jun 12, 2017: Kieran Murphy Appointed CEO of GE Healthcare, Succeeding John Flannery 33
6.2 May 31, 2017: Advanced Accelerator Applications Reports 21% Sales Growth for First Quarter 2017 34
6.3 May 30, 2017: Zecotek Receives $100,000 Order for Patented LFS Scintillation Crystals from Major Chinese OEM 35
6.4 May 25, 2017: Chinese OEMs Qualify LFS Scintillation Crystals for use in Positron Emission Tomography Medical Scanning Devices 36
6.5 May 25, 2017: Advanced Accelerator Applications Appoints Christine Mikail to Board of Directors 36
6.6 May 15, 2017: Threshold Pharmaceuticals Reports First Quarter Financial Results 37
6.7 Apr 07, 2017: PET radiotracer design for monitoring targeted immunotherapy 38
6.8 Mar 27, 2017: Threshold Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results 39
6.9 Mar 23, 2017: Advanced Accelerator Applications Reports 23% Sales Growth for Fiscal 2016; Continued NETSPOT Launch Success 41
6.10 Mar 21, 2017: Zecotek Provides Update to Chinese PET OEM MOU 42
6.11 Mar 21, 2017: AMITA Health Offers Unique Opportunity For Medicare Recipients To Determine Whether They Have Alzheimer's 43
6.12 Mar 09, 2017: Shanghai EBO Optoelectronics Company to Exclusively use Zecotek LFS Scintillation Crystals in China 45
6.13 Feb 14, 2017: Care and convenience for patients with new PET scanner at St George Hospital 45
6.14 Feb 14, 2017: ADDvise receives order from Consto AS worth 2,9 MNOK 46
6.15 Jan 25, 2017: Zecotek Signs LFS Scintillation Crystal Supply Agreement Worth $21 million Over the Next 3 Years 46
6.16 Dec 08, 2016: Advanced Accelerator Applications Announces CMS Pass-Through Reimbursement Code for its First FDA Approved Drug NETSPOT 47
6.17 Dec 07, 2016: Progenics Pharmaceuticals Announces First Patient Dosed in Phase 2/3 Clinical Trial of PSMA-Targeted PET/CT Imaging Agent PyL 48
6.18 Nov 28, 2016: Advanced Accelerator Applications Reports 15.4% Sales Growth in the Third Quarter of 2016 48
6.19 Nov 15, 2016: Rocky Mountain Cancer Centers First In Region to Offer Newly Approved Gallium DOTATATE PET/CT for Neuroendocrine Tumors 49
6.20 Nov 07, 2016: Threshold Pharmaceuticals Reports Third Quarter Financial Results 50
6.21 Nov 02, 2016: Advanced Accelerator Applications Announces Swiss Marketing Authorization for Two PET Diagnostic Products 52
6.22 Nov 01, 2016: GE Healthcare enhances single-use manufacturing capabilities with facility expansion and automation 52
6.23 Nov 01, 2016: Neuraceq Automated Synthesizer Synthera Received Shonin Approval in Japan 53
6.24 Oct 24, 2016: The Journal of Urology Publishes Blue Earth Diagnostics' Phase 3 Study Results of Axumin for PET Imaging of Recurrent Prostate Cancer 54
6.25 Oct 13, 2016: Chinese OEM Orders Zecotek's LFS Scintillation Crystals for Third Scanner 55
6.26 Oct 08, 2016: Oncovision will develop a technology for the early diagnosis of Alzheimer's disease 56
6.27 Oct 05, 2016: Mayo Clinic researchers map prostate cancer relapse using C-11 choline PET and MRI 57
6.28 Oct 04, 2016: Zecotek Announces Preliminary Revenue for Fiscal 2016 58
6.29 Oct 03, 2016: Jubilant DraxImage Receives FDA Approval for RUBY-FILL Rubidium 82 Generator and Elution System 58
6.30 Sep 26, 2016: FluoroPharma Announces CardioPET Phase II Results at the 21st American Society of Nuclear Cardiology (ASNC) Meeting 59
6.31 Sep 22, 2016: EMA Recommends Granting a Marketing Authorisation for Edotreotide 60
6.32 Sep 22, 2016: Lantheus to Present New Data at the ASNC Annual Scientific Session on the Novel PET Cardiac Imaging Agent Flurpiridaz F 18 in Patients with Suspected Heart Disease Undergoing Exercise Stress Testing 61
6.33 Sep 07, 2016: Bruker Unveils Next-Generation Preclinical Imaging Systems for Advanced Translational Research at World Molecular Imaging Congress 62
6.34 Aug 31, 2016: Advanced Accelerator Applications Reports 24.4% Sales Growth in the Second Quarter of 2016 63
6.35 Aug 03, 2016: Advanced Accelerator Applications Announces First Administration of NETSPOT at Holy Name Medical Center 64
6.36 Aug 01, 2016: Threshold Pharmaceuticals Reports Second Quarter Financial Results 65
6.37 Jul 28, 2016: Update on Chinese OEM Building PET Scanners 67
6.38 Jul 27, 2016: New Studies Suggest Relationship Between Tau Pathology And Progression Of Alzheimer's Disease 68
6.39 Jul 18, 2016: MabVax Therapeutics Initiates Patient Enrollment in a Phase I Trial for a New Diagnostic Imaging Product for Pancreatic Cancer 70
6.40 Jul 12, 2016: UCDavis Orders More LFS Crystals 70
6.41 Jul 12, 2016: Oncodesign Announces the Launch of Its First Clinical Study on a Radiotracer in Patients with Non-Small Cell Lung Cancer 71
6.42 Jul 08, 2016: New funding for the harmonisation and alignment of brain imaging methods 72
6.43 Jul 07, 2016: Two SwedishAmerican Physician Executives Assume New Positions 73
6.44 Jun 30, 2016: Zecotek receives second LFS Scintillation order for Radiation Safety and Homeland Security 73
6.45 Jun 24, 2016: Genome British Columbia Investing in Companies and Jobs Through e@UBC 74
7 Appendix 76
7.1 Methodology 76
7.2 About GlobalData 79
7.3 Contact Us 79
7.4 Disclaimer 79

1.1 List of Tables
Table 1: Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development 8
Table 2: Positron Emission Tomography (PET) Systems - Pipeline Products by Territory 9
Table 3: Positron Emission Tomography (PET) Systems - Pipeline Products by Regulatory Path 10
Table 4: Positron Emission Tomography (PET) Systems - Pipeline Products by Estimated Approval Date 11
Table 5: Positron Emission Tomography (PET) Systems Companies - Pipeline Products by Stage of Development 12
Table 6: Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development 13
Table 7: Brain Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 14
Table 8: CerePET - Product Status 14
Table 9: CerePET - Product Description 14
Table 10: GE Healthcare LLC Pipeline Products & Ongoing Clinical Trials Overview 15
Table 11: Q.Clear - Product Status 15
Table 12: Q.Clear - Product Description 15
Table 13: General De Equipment for Medical Imaging SA Pipeline Products & Ongoing Clinical Trials Overview 16
Table 14: CareMiBrain - Product Status 16
Table 15: CareMiBrain - Product Description 16
Table 16: Jagiellonian University Pipeline Products & Ongoing Clinical Trials Overview 17
Table 17: Positron Emission Tomography System - Product Status 17
Table 18: Positron Emission Tomography System - Product Description 17
Table 19: Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview 18
Table 20: Additional PET Scan - Product Status 18
Table 21: Additional PET Scan - Product Description 18
Table 22: Ray Vision Intl Corp. Pipeline Products & Ongoing Clinical Trials Overview 19
Table 23: Helmet - PET System - Product Status 19
Table 24: Helmet - PET System - Product Description 19
Table 25: Stanford University Pipeline Products & Ongoing Clinical Trials Overview 20
Table 26: Breast-Dedicated PET System - Product Status 20
Table 27: Breast-Dedicated PET System - Product Description 21
Table 28: Dual Panel PET Scanner - Product Status 21
Table 29: Dual Panel PET Scanner - Product Description 21
Table 30: Dual-isotope Positron Emitting Tomography System - Product Status 22
Table 31: Dual-isotope Positron Emitting Tomography System - Product Description 22
Table 32: MR Compatible PET System - Product Status 22
Table 33: MR Compatible PET System - Product Description 23
Table 34: PET Sensitivity Enhancing Device - Product Status 23
Table 35: PET Sensitivity Enhancing Device - Product Description 23
Table 36: PET System - Product Status 24
Table 37: PET System - Product Description 24
Table 38: SynchroPET Pipeline Products & Ongoing Clinical Trials Overview 25
Table 39: Breast PET-MRI - Product Status 25
Table 40: Breast PET-MRI - Product Description 25
Table 41: Wrist Scanner - Product Status 26
Table 42: Wrist Scanner - Product Description 26
Table 43: University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview 27
Table 44: PET Imaging Tool - Product Status 27
Table 45: PET Imaging Tool - Product Description 27
Table 46: University of Washington Pipeline Products & Ongoing Clinical Trials Overview 28
Table 47: DS-PS3 Positron Emission Tomography Detector - Product Status 28
Table 48: DS-PS3 Positron Emission Tomography Detector - Product Description 28
Table 49: High Resolution PET Detector - Product Status 29
Table 50: High Resolution PET Detector - Product Description 29
Table 51: PET-Mammogram-Biopsy System - Product Status 29
Table 52: PET-Mammogram-Biopsy System - Product Description 30
Table 53: West Virginia University Pipeline Products & Ongoing Clinical Trials Overview 31
Table 54: Positron Emission Tomography (PET) Imager - Product Status 31
Table 55: Positron Emission Tomography (PET) Imager - Product Description 31
Table 56: Zecotek Photonics Inc Pipeline Products & Ongoing Clinical Trials Overview 32
Table 57: New Generation PET Scanning Device - Product Status 32
Table 58: New Generation PET Scanning Device - Product Description 32
Table 59: Glossary 78

1.2 List of Figures
Figure 1: Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development 8
Figure 2: Positron Emission Tomography (PET) Systems - Pipeline Products by Territory 9
Figure 3: Positron Emission Tomography (PET) Systems - Pipeline Products by Regulatory Path 10
Figure 4: Positron Emission Tomography (PET) Systems - Pipeline Products by Estimated Approval Date 11

Filed in: Medical Device

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027 “Increased cases of traumatic injuries and increasing surgical procedures worldwide are driving the overall growth of the wound care market” The global wound care market is projected to reach USD 27.2 billion by 2027 from USD 20.8 billion in 2022, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such as increase in traumatic injuries, increased in number of surgical wounds and increased spending on traumatic wound management. On the other hand, challenges associated with wound care product validation and shortage of skilled professionals are the major factors hampering the growth of this market. “The advanced wound care products segment accounted for the highest growth rate in the wound care market, by product, during the forecast period” T......	$8150
Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027 “The rehabilitation equipment market is projected to grow at a CAGR of 5.9% between 2022 and 2027.” The global rehabilitation equipment market is projected to reach USD 19.8 billion by 2027 from USD 14.9 billion in 2022, at a CAGR of 5.9% during the forecast period. Increasing geriatric population and obese populations, increasing chronic diseases, high risk of injuries to caregivers during the manual handling of patients, and increasing demand for rehabilitation care, owing to an increasing access to healthcare are the key driving factors in the market. However, a lack of awareness and access to rehabilitation services in emerging countries is a major factor restraining market growth. “Therapy equipment was the largest and fastest-growing segment in the product segment of reha......	$4950
Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027 "Increasing sports injuries and active participation are driving the overall growth of the cold pain therapy market." The global cold pain therapy market is projected to reach USD 2.4 billion by 2027 from USD 1.8 billion in 2022, at a CAGR of 5.1% during the forecast period. Growth in this market is mainly driven by growing incidence of arthritis and availability of cold pain products at affordable cost. "The OTC products segment accounted for the highest growth rate in the cold pain therapy market, by product, during the forecast period." The cold pain therapy market is segmented into OTC products and prescription products based on product. In 2021, the OTC products segment accounted for the highest growth rate in the cold pain therapy market. Market growth can largely be attri......	$4950
Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027 “Increasing research investments into the neurological compilations and the expanding geriatric population are pushing the growth of the nerve repair & regeneration market.” The global nerve repair & regeneration market is expected to reach USD 11.6 billion by 2027 from USD 6.5 billion in 2022, at a CAGR of 12.1%.The growth in this market is driven by increasing research expenditure on the neurological disorders by the government, the increasing R&D investments by the market players into the neuromodulation and neurostimulation devices and the biomaterials. Also, the expanding geriatric population base dries the growth of the market by placing more demand of the nerve repair and regeneration products. “The biomaterialas segment is anticipated to grow at the fastest ......	$4950
Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027 MarketsandMarkets expects particle therapy market is projected to reach USD 1,004 million by 2027 from USD 677 million in 2022, growing at a CAGR of 8.2% from 2022 to 2027. Market growth is driven by factors such as the various advantages offered by the growing global prevalence of cancer, particle therapy advantages over photon therapy, increasing acceptance of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide. However, affordability & accessibility of treatments and infrastructural are expected to limit market growth to a certain extent in the coming years. In this report, the particle therapy market is segmented on the basis of type, product and services, cancer type, application, cancer type, and region. “Treatment Applicat......	$4950
Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027 “The global restorative dentistry market is projected to grow at a CAGR of 6.1%” Restorative dentistry restores mouth functions & its aesthetic state by efficiently managing oral health problems through dental restoration. Dental restoration procedures include the use of implants and prosthetics made by restorative material to restore the function, integrity, and morphology of the missing tooth or to repair the missing parts of the tooth structure resulted from dental caries or injuries. The global restorative dentistry market is projected to reach USD 22.2 billion by 2027 from USD 16.5 billion in 2022, at a CAGR of 6.1%. “The prosthetic materials segment is expected to account for the largest share of the restorative dentistry market” The prosthetic materials segment ......	$4950
Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027 “Rapid growth in the geriatric population and the associated increase in the prevalence of edentulism is expected to drive the overall growth of the dental laboratories market.” Edentulism (tooth loss) is a major oral health concern among the elderly; according to the WHO (2020), globally, ~19% of individuals aged between 65 and 74 years are edentulous. Periodontal diseases and dental cavities are the major causes of tooth loss. As the elderly are more susceptible to such ailments, the growth of this population segment will increase the number of people suffering from oral health problems globally. According to the UN, the global geriatric population (aged 65 years and above) will increase from 703 million in 2019 to 1.5 billion in 2050. Thus, significant growth in the geriatric pop......	$4950
Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027) “Endoscope reprocessing market is projected to grow at CAGR of 9.7% from 2022 to 2027” The global endoscope reprocessing market is projected to USD 3.8 billion by 2027 from USD 2.4 billion in 2022, at a CAGR of 9.7% from 2022 to 2027.The growth of this market is driven owing to increasing requirement for endoscopy to diagnose and treat target diseases, high risk of Endoscope-associated infections due to contaminated endoscopes, Growing geriatric population and leading to increase in endoscopic procedures, and Increasing emphasis on improving reprocessing guidelines by healthcare authorities. Also, Increasing investments, funds, and grants to improve healthcare infrastructure and research areas of endoscopy is anticipated to offer an opportunity for the growth of the market during th......	$4950
Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027 “Rising demand from the electronics industry and expected recovery from impact of COVID-19 and rising penetration of EVs expected to drive market.” The global Polymethyl Methacrylate (PMMA) market is projected to grow from USD 4.8 Billion in 2022 to USD 6.3 Billion by 2027, at a CAGR of 5.4% during the forecast period. Increasing usage of PMMA in construction, automotive, electronics, and other end-use industries are driving the demand for PMMA during the forecast period. However, availability of low-cost substitutes is expected to hamper market growth. PMMA is a versatile, recyclable, sustainable, and durable material, owing to which it is gaining traction across several industrial applications. Due to its superior properties and the changing government policies such as European Gr......	$4950
Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027 “The hospital laboratories is projected to grow at CAGR of 7.1% from 2022 to 2027” Based on End user the market is classified into, The hospital laboratories, clinical laboratories, and other end users . The growth of this market is majorly driven by the increasing number of specialty diagnostic tests performed in hospital laboratories, rising number of in-house clinical diagnostic procedures in hospitals, rising number of hospitals across the globe, and the growing trend of establishing in-house clinical diagnostic capabilities in hospitals. “Microtome instruments in the product segment to witness the highest shares during the forecast period.” Based on the product, the microtome market is segmented into Microtome Instruments: Rotary Microtomes, Cryostat Microtomes, Vibra......	$4950

Positron Emission Tomography (PET) Systems - Medical Devices Pipeline Assessment, 2017

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027

Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027

Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027

Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027

Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027

Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027

Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027

Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027)

Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027

Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027